cMET 失调的晚期实体瘤的临床试验
总计5784个结果
-
ABL Bio, Inc.National OncoVenture完全的
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, Germany终止晚期实体瘤西班牙, 美国, 荷兰, 匈牙利, 意大利, 法国, 比利时
-
Array Biopharma, now a wholly owned subsidiary...完全的
-
Belx Bio-Pharmaceutical (Taiwan) CorporationA2 Healthcare Taiwan Corporation终止
-
Astellas Pharma Global Development, Inc.完全的
-
PIQUR Therapeutics AG完全的
-
Bristol-Myers Squibb终止
-
National University Hospital, Singapore未知
-
Zhuhai Yufan Biotechnologies Co., Ltd招聘中
-
Zhuhai Yufan Biotechnologies Co., Ltd招聘中
-
Aadi Bioscience, Inc.招聘中
-
Bio-Thera Solutions尚未招聘
-
Canadian Cancer Trials GroupBristol-Myers Squibb; Cancer Research Institute, New York City; Personal Genome Diagnostics终止
-
National University Hospital, SingaporeINTRA-IMMUSG PRIVATE LIMITED未知
-
Georgetown UniversityWyeth is now a wholly owned subsidiary of Pfizer完全的
-
Amgen完全的癌症 | 晚期实体瘤 | 肿瘤学 | 肿瘤 | 晚期恶性肿瘤 | 肿瘤患者美国
-
University of California, San FranciscoMerck Sharp & Dohme LLC完全的
-
National Cancer Institute (NCI)招聘中